首页> 外文期刊>International journal of clinical oncology >Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs.
【24h】

Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs.

机译:恶病质的消化器官癌患者的Ghrelin和瘦素水平。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Cancer cachexia, a catabolic state characterized by weight loss, occurs frequently in patients with terminal-stage neoplastic diseases. Gastrointestinal hormones and cytokines may be associated with anorexia and wasting in cancer cachexia. METHODS: This study aimed to examine the mechanism of anorexia in cachectic patients through a prospective investigation of plasma cytokines, ghrelin, and leptin in 16 cachectic patients with cancer of the digestive organs and 10 healthy volunteers. RESULTS: Tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-1 receptor antagonist (IL-1Ra), and ghrelin levels were significantly higher in cachectic cancer patients than in the healthy volunteers, whereas leptin was significantly lower in the cachectic cancer patients. Plasma leptin levels and cytokine levels (TNF-alpha and IL-6) correlated significantly with body mass index (BMI), but plasma ghrelin levels did not correlate with BMI or with the grade of symptoms. CONCLUSION: Neither weight loss nor the grade of symptoms seemed to be directly associated with the increase in ghrelin levels. Hence, it is considered that the increase in ghrelin levels cannot simply be explained by an increase in ghrelin secretion, suggesting that other mechanisms, such as the decreased inactivation of ghrelin, may also play a role. Further studies are needed to clarify the mechanisms of the increase in ghrelin levels. Additionally, the changes in plasma cytokines (TNF-alpha and IL-6) and leptin in cachectic cancer patients suggest that these molecules may be useful markers for the evaluation of cancer cachexia.
机译:背景:癌症恶病质是一种以体重减轻为特征的分解代谢状态,在晚期肿瘤性疾病的患者中经常发生。胃肠激素和细胞因子可能与厌食症和癌症恶病质浪费有关。方法:本研究旨在通过对16名消化器官癌恶病质患者和10名健康志愿者的血浆细胞因子,生长素释放肽和瘦素的前瞻性研究来检查恶病质患者的厌食机制。结果:恶性肿瘤患者的肿瘤坏死因子(TNF)-α,白介素(IL)-6,IL-1受体拮抗剂(IL-1Ra)和生长素释放肽水平显着高于健康志愿者,而瘦素则显着降低在恶病质的癌症患者中。血浆瘦素水平和细胞因子水平(TNF-α和IL-6)与体重指数(BMI)显着相关,但血浆生长素释放肽水平与BMI或症状等级无关。结论:体重减轻和症状等级似乎均与生长素释放肽水平的升高没有直接关系。因此,认为生长素释放肽水平的增加不能简单地通过生长素释放肽分泌的增加来解释,表明其他机制,例如生长素释放肽的失活减少也可能起作用。需要进一步研究以阐明生长素释放肽水平升高的机制。此外,恶病质癌症患者血浆细胞因子(TNF-α和IL-6)和瘦素的变化表明,这些分子可能是评估癌症恶病质的有用标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号